Partial or complete antenatal steroids treatment and neonatal outcome in extremely low birth weight infants ≤ 1000 g: Is there a dose-dependent effect?

Walid A. Salhab, Linda S. Hynan, Jeffrey M. Perlman

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objectives: To assess the outcome of extremely low birth weight (ELBW) infants ≤1000 g as it relates to antenatal steroids (ANS) therapy. Study Design: A retrospective analysis of 124 infants born between January 1995 and December 1997. Infants born to mothers with pregnancy-induced hypertension, diabetes, and severe growth restriction were excluded. In all, 77 (62%) infants were exposed to ANS, of whom 31 (25%) received one to two doses (partial course), and 46 (37%) received three to four doses (complete course). A total of 47 infants (38%) were not exposed to ANS. Results: Infants not exposed to ANS, who exhibited more HMD, PDA, and IVH, were administered more surfactants, and were more likely to die versus infants with complete ANS dosing. Regression models revealed a dose-dependent effect of ANS on HMD, surfactant use, IVH, and CLD or death, with a significant decrease in HMD with ≥2 ANS doses. Conclusions: ANS, in a dose-dependent way, are associated with improved outcome in ELBW infants ≤1000 g, with the best outcome seen after a complete course.

Original languageEnglish (US)
Pages (from-to)668-672
Number of pages5
JournalJournal of Perinatology
Volume23
Issue number8
DOIs
StatePublished - Dec 2003

Fingerprint

Extremely Low Birth Weight Infant
Steroids
Surface-Active Agents
Pregnancy Induced Hypertension
Gestational Diabetes
Mothers

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Partial or complete antenatal steroids treatment and neonatal outcome in extremely low birth weight infants ≤ 1000 g : Is there a dose-dependent effect? / Salhab, Walid A.; Hynan, Linda S.; Perlman, Jeffrey M.

In: Journal of Perinatology, Vol. 23, No. 8, 12.2003, p. 668-672.

Research output: Contribution to journalArticle

@article{2f5e11c19b7041e5aa0be860d7a39e22,
title = "Partial or complete antenatal steroids treatment and neonatal outcome in extremely low birth weight infants ≤ 1000 g: Is there a dose-dependent effect?",
abstract = "Objectives: To assess the outcome of extremely low birth weight (ELBW) infants ≤1000 g as it relates to antenatal steroids (ANS) therapy. Study Design: A retrospective analysis of 124 infants born between January 1995 and December 1997. Infants born to mothers with pregnancy-induced hypertension, diabetes, and severe growth restriction were excluded. In all, 77 (62{\%}) infants were exposed to ANS, of whom 31 (25{\%}) received one to two doses (partial course), and 46 (37{\%}) received three to four doses (complete course). A total of 47 infants (38{\%}) were not exposed to ANS. Results: Infants not exposed to ANS, who exhibited more HMD, PDA, and IVH, were administered more surfactants, and were more likely to die versus infants with complete ANS dosing. Regression models revealed a dose-dependent effect of ANS on HMD, surfactant use, IVH, and CLD or death, with a significant decrease in HMD with ≥2 ANS doses. Conclusions: ANS, in a dose-dependent way, are associated with improved outcome in ELBW infants ≤1000 g, with the best outcome seen after a complete course.",
author = "Salhab, {Walid A.} and Hynan, {Linda S.} and Perlman, {Jeffrey M.}",
year = "2003",
month = "12",
doi = "10.1038/sj.jp.7211007",
language = "English (US)",
volume = "23",
pages = "668--672",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Partial or complete antenatal steroids treatment and neonatal outcome in extremely low birth weight infants ≤ 1000 g

T2 - Is there a dose-dependent effect?

AU - Salhab, Walid A.

AU - Hynan, Linda S.

AU - Perlman, Jeffrey M.

PY - 2003/12

Y1 - 2003/12

N2 - Objectives: To assess the outcome of extremely low birth weight (ELBW) infants ≤1000 g as it relates to antenatal steroids (ANS) therapy. Study Design: A retrospective analysis of 124 infants born between January 1995 and December 1997. Infants born to mothers with pregnancy-induced hypertension, diabetes, and severe growth restriction were excluded. In all, 77 (62%) infants were exposed to ANS, of whom 31 (25%) received one to two doses (partial course), and 46 (37%) received three to four doses (complete course). A total of 47 infants (38%) were not exposed to ANS. Results: Infants not exposed to ANS, who exhibited more HMD, PDA, and IVH, were administered more surfactants, and were more likely to die versus infants with complete ANS dosing. Regression models revealed a dose-dependent effect of ANS on HMD, surfactant use, IVH, and CLD or death, with a significant decrease in HMD with ≥2 ANS doses. Conclusions: ANS, in a dose-dependent way, are associated with improved outcome in ELBW infants ≤1000 g, with the best outcome seen after a complete course.

AB - Objectives: To assess the outcome of extremely low birth weight (ELBW) infants ≤1000 g as it relates to antenatal steroids (ANS) therapy. Study Design: A retrospective analysis of 124 infants born between January 1995 and December 1997. Infants born to mothers with pregnancy-induced hypertension, diabetes, and severe growth restriction were excluded. In all, 77 (62%) infants were exposed to ANS, of whom 31 (25%) received one to two doses (partial course), and 46 (37%) received three to four doses (complete course). A total of 47 infants (38%) were not exposed to ANS. Results: Infants not exposed to ANS, who exhibited more HMD, PDA, and IVH, were administered more surfactants, and were more likely to die versus infants with complete ANS dosing. Regression models revealed a dose-dependent effect of ANS on HMD, surfactant use, IVH, and CLD or death, with a significant decrease in HMD with ≥2 ANS doses. Conclusions: ANS, in a dose-dependent way, are associated with improved outcome in ELBW infants ≤1000 g, with the best outcome seen after a complete course.

UR - http://www.scopus.com/inward/record.url?scp=0346957157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346957157&partnerID=8YFLogxK

U2 - 10.1038/sj.jp.7211007

DO - 10.1038/sj.jp.7211007

M3 - Article

C2 - 14647166

AN - SCOPUS:0346957157

VL - 23

SP - 668

EP - 672

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 8

ER -